Bailey Don M's Form 4 filing
Lineage Cell Therapeutics, Inc. (LCTX) · filed Feb 8, 2024
- Accession no.
- 0001493152-24-005510
- Filed
- Feb 8, 2024
- Trade date
- Feb 8, 2024
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $100.0K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bailey Don MCIK 0001223697 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 8, 2024 | Common Shares, no par value | PPurchaseAcquired | +96,155 | $1.04 | +$100,001.2 | 158,801 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.